ADAPTIVE BIOTECHNOLOGIES COR's ticker is and the CUSIP is 00650F909. A total of 4 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $218,000 | +2607.4% | 40,000 | +3233.3% | 0.00% | – |
| Q2 2023 | $8,052 | -97.7% | 1,200 | -96.9% | 0.00% | -100.0% |
| Q1 2023 | $346,136 | +45205.8% | 39,200 | +39100.0% | 0.00% | – |
| Q4 2022 | $764 | -98.0% | 100 | -98.1% | 0.00% | – |
| Q3 2022 | $38,000 | +1166.7% | 5,400 | +1250.0% | 0.00% | – |
| Q2 2022 | $3,000 | +200.0% | 400 | +300.0% | 0.00% | – |
| Q1 2022 | $1,000 | -99.3% | 100 | -98.1% | 0.00% | – |
| Q4 2021 | $146,000 | +151.7% | 5,200 | +205.9% | 0.00% | – |
| Q3 2021 | $58,000 | -91.2% | 1,700 | -89.4% | 0.00% | -100.0% |
| Q2 2021 | $658,000 | +928.1% | 16,100 | +906.2% | 0.00% | – |
| Q1 2021 | $64,000 | -95.1% | 1,600 | -92.7% | 0.00% | -100.0% |
| Q4 2020 | $1,295,000 | -58.4% | 21,900 | -65.8% | 0.00% | -80.0% |
| Q3 2020 | $3,112,000 | +48.9% | 64,000 | +48.1% | 0.01% | 0.0% |
| Q2 2020 | $2,090,000 | +414.8% | 43,200 | +195.9% | 0.01% | +233.3% |
| Q1 2020 | $406,000 | +247.0% | 14,600 | +274.4% | 0.00% | +200.0% |
| Q4 2019 | $117,000 | +244.1% | 3,900 | +254.5% | 0.00% | – |
| Q3 2019 | $34,000 | – | 1,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PURA VIDA INVESTMENTS, LLC | 750,000 | $5,730,000 | 0.30% |
| GROUP ONE TRADING, L.P. | 100 | $764 | 0.00% |
| SIMPLEX TRADING, LLC | 8,300 | $63 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |